SLC16A1 and malignant urinary system neoplasm: Specifically, lncRNAs such as LUCAT1, MAFG-AS1, RP11-89, OIP5-AS1, and SLC16A1-AS1 exert their effects by regulating ferroptosis-related genes, thereby impacting the development and management of urinary system cancers.